﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/iphex-2025-piyush-goyal-calls-for-deeper-global-collaborations-to-strengthen-healthcare-systems-worldwide-17726</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-expands-medtronic-minimed-780g-system-17737</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/quotient-sciences-and-cpi-join-forces-to-accelerate-rna-drug-development-17736</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/resolution-therapeutics-doses-first-patient-in-phase-iii-emerald-study-of-rtx001-for-end-stage-liver-disease-17735</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/capvest-to-acquire-majority-stake-in-stada-17734</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/astrazenecas-baxdrostat-proves-effective-in-in-phase-iii-trial-for-hard-to-control-hypertension-17733</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-completes-inspection-at-biocon-biologics-facility-in-bengaluru-17732</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/edwards-lifesciences-launches-next-gen-transcatheter-heart-valve-in-india-17731</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/zydus-and-synthon-ink-licensing-and-supply-agreement-for-ozanimod-capsules-for-us-market-17730</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/medtech-expo-2025-icmr-licenses-nine-technologies-to-17-industry-partners-17729</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/dpiit-signs-mou-with-pfizer-to-strengthen-indias-healthcare-innovation-ecosystem-17728</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/granules-india-and-niper-sas-nagar-launch-coe-for-sustainable-pharma-innovation-17727</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sanofis-amlitelimab-met-all-primary-and-key-secondary-endpoints-in-the-coast-1-phase-3-study-in-adults-and-adolescents-with-atopic-dermatitis-17738</loc><lastmod>2025-09-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>